Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
NCT00083382
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
83
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Pamidronate
DRUG:
Thalidomide
DRUG:
Zometa
Sponsor
University of Arkansas